Christopher Visioli
Director of Finance/CFO bij POPULATION HEALTH INVESTMENT CO., INC.
Profiel
De heer Christopher Visioli is Chief Financial Officer bij Population Health Investment Co, Inc. en Chief Financial & Accounting Officer bij The Medicines Co. De heer Visioli was voorheen werkzaam als Senior Vice President-Financial Strategy bij The Medicines Co. Hij behaalde zijn doctoraal aan de Cornell University en een MBA aan de Columbia Business School.
Actieve functies van Christopher Visioli
| Bedrijven | Functie | Begin |
|---|---|---|
| POPULATION HEALTH INVESTMENT CO., INC. | Director of Finance/CFO | 11-09-2020 |
Eerdere bekende functies van Christopher Visioli
| Bedrijven | Functie | Einde |
|---|---|---|
| THE MEDICINES COMPANY | Director of Finance/CFO | 01-05-2020 |
Opleiding van Christopher Visioli
| Cornell University | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
Population Health Investment Co., Inc.
 Population Health Investment Co., Inc. Financial ConglomeratesFinance Population Health Investment Co., Inc. operates as a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase and reorganization or similar business combination with one or more businesses. It intends to focus on companies in the healthcare industry such as the therapeutics sector. The company was founded by Clive A. Meanwell and Ian C. Read on September 11, 2020 and is headquartered in New York, NY. | Finance |
